Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2009-05-31
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Routine Fetal RhD Genotyping for RhD- Pregnant Women
NCT00832962
Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
NCT06690099
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346
Development of New Prenatal Diagnostic Tests From Maternal Blood
NCT00314691
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
NCT03620110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is female
* Subject is pregnant
* Subject is RhD negative
* Subject is between 10 and 28 weeks gestation
* Subject provides informed consent
* Subject agrees to provide neonatal RHD and sex outcome
Exclusion Criteria
18 Years
64 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sequenom Center for Molecular Medicine
UNKNOWN
Sequenom, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sharp Grossmont Hospital
San Diego, California, United States
West Coast OBGYN
San Diego, California, United States
Women's Health Care, Inc
San Diego, California, United States
Scripps Hospitals (5 San Diego locations)
San Diego, California, United States
Spectrum Health Research
Grand Rapids, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SQNM-RHD-105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.